Retaglutide and tirzepatide are innovative GLP-1 receptor agonists gaining recognition as effective treatment options for type 2 diabetes. These medications enhance insulin secretion from the pancreas, reduce glucagon https://elaineogpo470812.wikiinside.com/3273245/emerging_therapies_for_type_2_diabetes